石药集团:与MADRIGAL就SYH2086订立独家授权协议

金吾资讯
Jul 30

金吾财讯 | 石药集团(01093)公布,已与Madrigal Pharmaceuticals, Inc.就集团的口服小分子激活胰高血糖素样肽-1(GLP -1)受体激动剂SYH2086在全球的开发、生产及商业化订立独家授权协议。根据该协议的条款,石药同意授予Madrigal在全球范围内开发、生产及商业化SYH2086的独家授权,同时保留本集团 在中国开发和销售其他口服小分子GLP -1 受体...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10